STERIS Plc Income Tax Expense Over Time
| STE Stock | USD 214.34 1.43 0.66% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out STERIS Plc Performance and STERIS Plc Correlation. STERIS |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.305 | Dividend Share 2.13 | Earnings Share 5.96 | Revenue Per Share 53.903 | Quarterly Revenue Growth 0.073 |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Income Tax Expense Analysis
Compare STERIS plc and related stocks such as Orthofix Medical, NuVasive, and Glaukos Corp Income Tax Expense Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OFIX | (5 M) | 21.8 M | 28.8 M | 9.2 M | 16.2 M | 10.8 M | 15.5 M | 29.1 M | 9.1 M | 1.4 M | (2.9 M) | 24.9 M | 2 M | 2.7 M | 2.6 M |
| GKOS | 3 K | 3 K | 3 K | 6 K | 18 K | 33 K | 43 K | 93 K | 583 K | (65.5 M) | (12 M) | 326 K | 766 K | 934 K | 980.7 K |
| BRKR | 986.9 K | 51.5 M | 60.1 M | 42.8 M | 41.7 M | 23.1 M | 23.1 M | 117.5 M | 63.7 M | 82.4 M | 64.4 M | 113 M | 116.4 M | 117.7 M | 123.6 M |
| CNMD | 500 K | (3.1 M) | 19 M | 14.7 M | 14.5 M | 14.6 M | 4.7 M | (26.8 M) | 9.8 M | 2.6 M | (7.9 M) | 10.6 M | 9.7 M | 16.4 M | 17.2 M |
| ANIK | (300 K) | 5.3 M | 7.8 M | 11.9 M | 23.2 M | 17.5 M | 18.3 M | 14.4 M | 4.5 M | 8.9 M | (4.6 M) | (1.7 M) | (3.9 M) | (2.7 M) | (2.5 M) |
| ITGR | (605 K) | 15.3 M | 11.5 M | 12.6 M | 21.1 M | (8.1 M) | (4.8 M) | (44.9 M) | 14.1 M | 14 M | 8.9 M | 8 M | 10.6 M | 16.6 M | 17.5 M |
| ZIMV | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | 200 K | (42.3 M) | (6 M) | (46 M) | 5.2 M | 5.5 M |
| SYK | 6.7 M | 341 M | 407 M | 206 M | 645 M | 296 M | 274 M | 1 B | (1.2 B) | 479 M | 355 M | 287 M | 325 M | 508 M | 533.4 M |
| BSX | 26.3 M | 201 M | (39 M) | (102 M) | (176 M) | (411 M) | (170 M) | 828 M | (249 M) | (4 B) | 2 M | 36 M | 443 M | 393 M | 412.6 M |
| SNN | 33.1 M | 266 M | 371 M | 246 M | 213 M | 149 M | 278 M | 112 M | 118 M | 143 M | 202 M | 62 M | 12 M | 27 M | 25.6 M |
| LIVN | (800 K) | 24.3 M | 28.9 M | 25 M | 31.4 M | (13 M) | 7.1 M | 50 M | (69.6 M) | (30.2 M) | (700 K) | 11.2 M | 11.1 M | (98.9 M) | (93.9 M) |
| IRTC | 481 K | 481 K | 481 K | 481 K | 481 K | 950 K | 607 K | 3 M | 44 K | 65 K | 229 K | 367 K | 269 K | 750 K | 543 K |
| PODD | 12.6 M | 127 K | 212 K | 100 K | 142 K | 212 K | 392 K | 257 K | 1.9 M | 2.9 M | 2.9 M | 3.7 M | 5.2 M | 8.3 M | 8.7 M |
| PEN | 1.9 M | 1.9 M | 1.9 M | (5.4 M) | 894 K | 1.7 M | (15.7 M) | (3.6 M) | (4.4 M) | 3.1 M | (18.8 M) | (13.1 M) | 5.9 M | (11.3 M) | (10.7 M) |
| MASI | 400 K | 22.5 M | 21.9 M | 20 M | 27.7 M | 34.8 M | 117.7 M | 67.8 M | 20.2 M | 38 M | 23.5 M | 44.7 M | 49.9 M | 6.6 M | 6.3 M |
STERIS plc and related stocks such as Orthofix Medical, NuVasive, and Glaukos Corp Income Tax Expense description
My Equities
My Current Equities and Potential Positions
| STERIS plc | STE |
| Classification | Medical Equipment |
| Location | Ireland |
| Exchange | New York Stock Exchange |
USD 214.34
Check out STERIS Plc Performance and STERIS Plc Correlation. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
STERIS Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.